Cambridge Healthtech Institute :Seventh Annual Predictive Cancer Biomarkers

Biomarker-based cancer diagnostics are making their way to the forefront of cancer treatment. Still, in order to continue moving personalized cancer therapy to clinic, researchers must discover new markers and improve detection specificity.

Robust methods and increased informatics capabilities need to be improved to keep up with the volume of data being generated. Cambridge Healthtech Institute's Seventh Annual Predictive Cancer Biomarkers will focus on the steps needed to manage the new treatment paradigm from treating clinical symptoms to targeting genomic pathways. Top cancer researchers will present their latest discoveries, case studies, and best practices to decrease late-stage diagnosis and improve patient outcomes.

Who should attend: Pathologists, Oncologists, Medical Directors, Vice Presidents, CMOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in areas such as cancer biomarkers, bioinformatics, clinical genomics, diagnostics, internal medicine, molecular biology, and translational research.